Dr. Soliman Abdul Kader Fakeeh Hospital Co. vs Mouwasat Medical Services Co.
A head-to-head of Dr. Soliman Abdul Kader Fakeeh Hospital Co. (4017) and Mouwasat Medical Services Co. (4002) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
Dr. Soliman Abdul Kader Fakeeh Hospital Co.
4017
34.76 SAR
-1.03%
VS
Mouwasat Medical Services Co.
4002
60.90 SAR
+0.25%
| Metric | 4017 | 4002 |
|---|---|---|
| Market Cap | 8.01B SAR | 12.18B SAR |
| P/E (TTM) | 30.23 | 14.82 |
| Forward P/E | 21.07 | 13.87 |
| P/S | 2.59 | 4.02 |
| P/B | 2.51 | 3.06 |
| EV/EBITDA | 22.21 | 12.54 |
| Dividend Yield | — | 6.24% |
| Profit Margin | 8.77% | 25.09% |
| Gross Margin | 19.32% | 42.25% |
| Operating Margin | 6.16% | 26.98% |
| Revenue Growth (YoY) | -2.50% | +9.09% |
| FCF Yield | -2.30% | 5.10% |
| Debt / Equity | 20.66 | 28.00 |
| Current Ratio | 1.65 | 1.62 |
Which is better: Dr. Soliman Abdul Kader Fakeeh Hospital Co. or Mouwasat Medical Services Co.?
- ✓Larger by market cap: Mouwasat Medical Services Co.
- ✓Cheaper valuation (lower P/E): Mouwasat Medical Services Co.
- ✓More profitable (net margin): Mouwasat Medical Services Co.
- ✓Faster revenue growth: Mouwasat Medical Services Co.
- ✓Higher free-cash-flow yield: Mouwasat Medical Services Co.
Across 12 available metrics, Mouwasat Medical Services Co. leads 8–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Dr. Soliman Abdul Kader Fakeeh Hospital Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.